NewLink Genetics (Ebola vaccine)

Business Data, Corporate Office and Headquarter Address

About

NewLink Genetics (Ebola vaccine) is Buildings and Property in United States that focus on Ebola business. They cover business area such as Ebola, rVSV-EBOV, Canada, phase-I clinical trial.

Business Type

Buildings and Property

Country

United States

Founded

-

Company Focus

Ebola

Website

-

Corporate Office and Headquarter Office address:

Ames, IA
United States

Phone number:

Private

Office Opening Hours*:

Monday 9.30 - 17.00
Tuesday 9.30 - 17.00
Wednesday 9.30 - 17.00
Thursday 9.30 - 17.00
Friday 9.30 - 17.00
Saturday Closed
Sunday Closed

Business Coverage

EbolarVSV-EBOVCanadaphase-I clinical trial

* We use standard office opening hours in near NewLink Genetics (Ebola vaccine)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.

NewLink Genetics (Ebola vaccine) Frequently Asked Questions

What or who is NewLink Genetics (Ebola vaccine)?

NewLink Genetics (Ebola Vaccine) is Buildings and Property business from United States that founded in - ( years old in ), NewLink Genetics (Ebola vaccine) business is focusing on Ebola.

Where is NewLink Genetics (Ebola vaccine) headquarter and corporate office address?

NewLink Genetics (Ebola vaccine) headquarter office and corporate office address is located in Ames, IA United States.

Where is NewLink Genetics (Ebola vaccine) country origins?

NewLink Genetics (Ebola vaccine) was founded in United States.

What is Ebola business focus on?

In , NewLink Genetics (Ebola vaccine) is currently focus on Ebola sector.

Disclaimer: This website is not affiliated with NewLink Genetics (Ebola vaccine), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.